天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 33100-27-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 33100-27-5
Chemical Structure| 33100-27-5
Structure of 33100-27-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 33100-27-5 ]

Related Doc. of [ 33100-27-5 ]

Alternatived Products of [ 33100-27-5 ]
Product Citations

Product Citations

Mehedi H. Rizvi ; Ruosong Wang ; Jonas Schubert , et al. DOI: PubMed ID:

Abstract: Plasmonic nanoparticles that can be manipulated with magnetic fields are of interest for advanced optical applications, diagnostics, imaging, and therapy. Alignment of gold nanorods yields strong polarization-dependent extinction, and use of magnetic fields is appealing because they act through space and can be quickly switched. In this work, cationic polyethyleneimine-functionalized superparamagnetic Fe3O4 nanoparticles (NPs) are deposited on the surface of anionic gold nanorods coated with bovine serum albumin. The magnetic gold nanorods (MagGNRs) obtained through mixing maintain the distinct optical properties of plasmonic gold nanorods that are minimally perturbed by the magnetic overcoating. Magnetic alignment of the MagGNRs arising from magnetic dipolar interactions on the anisotropic gold nanorod core is comprehensively characterized, including structural characterization and enhancement (suppression) of the longitudinal surface plasmon resonance and suppression (enhancement) of the transverse surface plasmon resonance for light polarized parallel (orthogonal) to the magnetic field. The MagGNRs can also be driven in rotating magnetic fields to rotate at frequencies of at least 17 Hz. For suitably large gold nanorods (148 nm long) and Fe3O4 NPs (13.4 nm diameter), significant alignment is possible even in modest (<500 Oe) magnetic fields. An analytical model provides a unified understanding of the magnetic alignment of MagGNRs.

Purchased from AmBeed:

Product Details of [ 33100-27-5 ]

CAS No. :33100-27-5 MDL No. :MFCD00005110
Formula : C10H20O5 Boiling Point : -
Linear Structure Formula :(CH2CH2)5O5 InChI Key :VFTFKUDGYRBSAL-UHFFFAOYSA-N
M.W : 220.26 Pubchem ID :36336
Synonyms :
Chemical Name :1,4,7,10,13-Pentaoxacyclopentadecane

Calculated chemistry of [ 33100-27-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 53.49
TPSA : 46.15 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.98 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.2
Log Po/w (XLOGP3) : -0.48
Log Po/w (WLOGP) : 0.08
Log Po/w (MLOGP) : -1.04
Log Po/w (SILICOS-IT) : 1.6
Consensus Log Po/w : 0.47

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.9
Solubility : 27.5 mg/ml ; 0.125 mol/l
Class : Very soluble
Log S (Ali) : -0.02
Solubility : 209.0 mg/ml ; 0.95 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.37
Solubility : 9.33 mg/ml ; 0.0424 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.06

Safety of [ 33100-27-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 33100-27-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 33100-27-5 ]

[ 33100-27-5 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 82401-08-9 ]
  • [ 33100-27-5 ]
  • [ 120068-37-3 ]
  • 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-methylsulfenyl-5-(1-oxy-pyridin-3-ylmethylamino)pyrazole-3-carbonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
With hydrogenchloride; In water; ethyl acetate; N,N-dimethyl-formamide; EXAMPLE 3 Production of 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-methylsulfenyl-5-(1-oxy-pyridin-3-ylmethylamino)pyrazole-3-carbonitrile (Compound No. 14) In 10 ml of N,N-dimethylformamide was suspended 0.1 g of 60% sodium hydride, and 1 g of 5-amino-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-trifluoromethylsulfinylpyrazole-3-carbonitrile was gradually added thereto. After 20 minutes of stirring at room temperature, 3 drops of 15-crown-5-ether and then 0.3 g of 3-chloromethylpyridine-1-oxide were added thereto, followed by stirring at room temperature. After standing over one night, water and ethyl acetate were added thereto and the mixture was neutralized by 1N hydrochloric acid. After liquid separation, the organic layer was washed with saturated saline and then dried over anhydrous sodium sulfate. The residue was purified by a silica gel column chromatography to obtain 0.9 g of the compound (No. 14) described in the following Table 1.
  • 2
  • [ 7631-99-4 ]
  • [ 33100-27-5 ]
  • uranyl nirate hexahydrate [ No CAS ]
  • [ 610-09-3 ]
  • [(uranyl)4(sodium)2(cis-1,2-cyclohexanedicarboxylate)2(oxalate)3(15-crown-5)2] [ No CAS ]
Recommend Products
Same Skeleton Products
Historical Records
; ;